XML 15 R33.htm IDEA: XBRL DOCUMENT v3.19.3
Stockholders' Equity (Tables)
9 Months Ended
Sep. 27, 2019
Stockholders Equity Note [Abstract]  
Schedule of Compensation Cost

The cost that has been charged against income for stock-based compensation is set forth below (in thousands):

 

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

 

September 27,

2019

 

 

September 28,

2018

 

 

September 27,

2019

 

 

September 28,

2018

 

Employee stock options

 

$

2,178

 

 

$

1,197

 

 

$

5,770

 

 

$

2,713

 

Restricted stock

 

 

77

 

 

 

82

 

 

 

236

 

 

 

192

 

Restricted stock units

 

 

246

 

 

 

501

 

 

 

1,661

 

 

 

1,593

 

Nonemployee stock options

 

 

57

 

 

 

247

 

 

 

111

 

 

 

428

 

Total stock-based compensation expense

 

$

2,558

 

 

$

2,027

 

 

$

7,778

 

 

$

4,926

 

 

Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs

The Company recorded stock-based compensation costs in the following categories (in thousands):

 

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

 

September 27,

2019

 

 

September 28,

2018

 

 

September 27,

2019

 

 

September 28,

2018

 

Cost of sales

 

$

7

 

 

$

4

 

 

$

43

 

 

$

11

 

General and administrative

 

 

1,082

 

 

 

701

 

 

 

2,878

 

 

 

1,875

 

Marketing and selling

 

 

692

 

 

 

471

 

 

 

2,553

 

 

 

1,297

 

Research and development

 

 

777

 

 

 

851

 

 

 

2,304

 

 

 

1,743

 

Total stock-based compensation expense, net

 

 

2,558

 

 

 

2,027

 

 

 

7,778

 

 

 

4,926

 

Amounts capitalized as part of inventory

 

 

258

 

 

 

182

 

 

 

723

 

 

 

449

 

Total stock-based compensation expense, gross

 

$

2,816

 

 

$

2,209

 

 

$

8,501

 

 

$

5,375

 

 

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions The risk-free rate is based on the U.S. Treasury yield curve corresponding to the expected term at the time of the grant.

 

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

 

September 27,

2019

 

 

September 28,

2018

 

 

September 27,

2019

 

 

September 28,

2018

 

Expected dividend yield

 

 

0

%

 

 

0

%

 

 

0

%

 

 

0

%

Expected volatility

 

 

53

%

 

 

53

%

 

 

53

%

 

 

53

%

Risk-free interest rate

 

 

1.55

%

 

 

2.84

%

 

 

2.40

%

 

 

2.71

%

Expected term (in years)

 

 

5.67

 

 

 

5.72

 

 

 

5.67

 

 

 

5.72

 

 

Schedule of Share-based Compensation, Stock Options, Activity

A summary of stock option activity under the Plan for the nine months ended September 27, 2019 is presented below:

 

 

 

Stock

Options

(in 000’s)

 

 

Minimum

Exercise

Price

 

 

Maximum

Exercise

Price

 

Outstanding at December 28, 2018

 

 

3,920

 

 

 

 

 

 

 

 

 

Granted

 

 

818

 

 

 

 

 

 

 

 

 

Exercised

 

 

(190

)

 

 

 

 

 

 

 

 

Forfeited or expired

 

 

(23

)

 

 

 

 

 

 

 

 

Outstanding at September 27, 2019

 

 

4,525

 

 

$

3.50

 

 

$

43.84

 

Exercisable at September 27, 2019

 

 

3,104

 

 

 

 

 

 

 

 

 

 

Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity

A summary of restricted stock and RSU activity under the Plan for the nine months ended September 27, 2019 is presented below:

 

 

 

Restricted

Stock

(in 000’s)

 

 

Restricted

Stock

Units

(in 000’s)

 

Unvested at December 28, 2018

 

 

11

 

 

 

322

 

Granted

 

 

11

 

 

 

19

 

Vested

 

 

(11

)

 

 

(210

)

Forfeited or expired

 

 

 

 

 

(6

)

Unvested at September 27, 2019

 

 

11

 

 

 

125